Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of de novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the role of Radiotherapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Lancia A, Alitto AR, Pappagallo G, Ciurlia E, Francolini G, D'Angelillo R, Fersino S, Levra NG, Jereczek-Fossa BA, Magli A, Pasqualetti F, Reali A, Spatola C, Triggiani L. Lancia A, et al. Among authors: magli a. Pract Radiat Oncol. 2024 Oct 26:S1879-8500(24)00287-X. doi: 10.1016/j.prro.2024.10.007. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 39490734 Free article.
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO).
D'Angelillo RM, Francolini G, Ingrosso G, Ravo V, Triggiani L, Magli A, Mazzeo E, Arcangeli S, Alongi F, Jereczek-Fossa BA, Pergolizzi S, Pappagallo GL, Magrini SM. D'Angelillo RM, et al. Among authors: magli a. Crit Rev Oncol Hematol. 2019 Jun;138:24-28. doi: 10.1016/j.critrevonc.2019.03.014. Epub 2019 Apr 1. Crit Rev Oncol Hematol. 2019. PMID: 31092381 Review.
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Francolini G, Borghesi S, Fersino S, Magli A, Jereczek-Fossa BA, Cristinelli L, Rizzo M, Corvò R, Pappagallo GL, Arcangeli S, Magrini SM, D'Angelillo RM. Francolini G, et al. Among authors: magli a. Crit Rev Oncol Hematol. 2021 Mar;159:103235. doi: 10.1016/j.critrevonc.2021.103235. Epub 2021 Jan 22. Crit Rev Oncol Hematol. 2021. PMID: 33493633 Free article. Review.
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study.
Triggiani L, Alongi F, Buglione M, Detti B, Santoni R, Bruni A, Maranzano E, Lohr F, D'Angelillo R, Magli A, Bonetta A, Mazzola R, Pasinetti N, Francolini G, Ingrosso G, Trippa F, Fersino S, Borghetti P, Ghirardelli P, Magrini SM. Triggiani L, et al. Among authors: magli a. Br J Cancer. 2017 Jun 6;116(12):1520-1525. doi: 10.1038/bjc.2017.103. Epub 2017 Apr 27. Br J Cancer. 2017. PMID: 28449007 Free PMC article.
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.
Triggiani L, Mazzola R, Magrini SM, Ingrosso G, Borghetti P, Trippa F, Lancia A, Detti B, Francolini G, Matrone F, Bortolus R, Fanetti G, Maranzano E, Pasqualetti F, Paiar F, Bonù ML, Magli A, Bruni A, Mazzeo E, Franzese C, Scorsetti M, Alongi F, Jereczek-Fossa BA, Ost P, Buglione M. Triggiani L, et al. Among authors: magli a. World J Urol. 2019 Dec;37(12):2631-2637. doi: 10.1007/s00345-019-02717-7. Epub 2019 Mar 11. World J Urol. 2019. PMID: 30859273
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO).
Mazzeo E, Triggiani L, Frassinelli L, Guarneri A, Bartoncini S, Antognoni P, Gottardo S, Greco D, Borghesi S, Nanni S, Bruni A, Ingrosso G, D'Angelillo RM, Detti B, Francolini G, Magli A, Guerini AE, Arcangeli S, Spiazzi L, Ricardi U, Lohr F, Magrini SM. Mazzeo E, et al. Among authors: magli a. Cancers (Basel). 2021 May 30;13(11):2702. doi: 10.3390/cancers13112702. Cancers (Basel). 2021. PMID: 34070797 Free PMC article.
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Jereczek-Fossa BA, Pepa M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovò M, Ricardi U, Magrini SM, Corvò R, Donato V; AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: magli a. Radiother Oncol. 2020 Aug;149:89-93. doi: 10.1016/j.radonc.2020.04.061. Epub 2020 May 12. Radiother Oncol. 2020. PMID: 32413527 Free PMC article.
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.
Triggiani L, Mazzola R, Tomasini D, Bruni A, Alicino G, Matrone F, Bortolus R, Francolini G, Detti B, Magli A, Bonù ML, Ingrosso G, Lancia A, Trippa F, Maranzano E, Franzese C, Ghirardelli P, Vavassori V, Scorsetti M, Alongi F, Magrini SM. Triggiani L, et al. Among authors: magli a. Med Oncol. 2021 May 18;38(6):72. doi: 10.1007/s12032-021-01518-6. Med Oncol. 2021. PMID: 34008151 Free PMC article.
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial.
Bonù ML, Magli A, Tomasini D, Frassine F, Albano D, Arcangeli S, Bruni A, Ciccarelli S, De Angeli M, Francolini G, Franzese C, Ghirardelli P, Grazioli L, Guerini A, Lancia A, Marvaso G, Sepulcri M, Trodella LE, Morelli V, Georgopulos A, Domina AO, Granello L, Mataj E, Barbera F, Triggiani L. Bonù ML, et al. Among authors: magli a. BJR Open. 2022 Nov 29;4(1):20220032. doi: 10.1259/bjro.20220032. eCollection 2022. BJR Open. 2022. PMID: 38525170 Free PMC article.
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2.
Jereczek-Fossa BA, Pepa M, Zaffaroni M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovo M, Leonardi MC, Ricardi U, Magrini SM, Corvò R, Donato V; on the behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: magli a. Radiother Oncol. 2021 Feb;155:120-122. doi: 10.1016/j.radonc.2020.09.049. Epub 2020 Oct 14. Radiother Oncol. 2021. PMID: 33065185 Free PMC article. No abstract available.
192 results